Keywords
Abstract
The 2021/2022 influenza season was not characterised by a well-defined incidence peak. As reported by the Italian National Institute of Health, a high value of incidence of influenza cases was recorded in week 13, but it was still lower than in other influenza seasons. This abnormal circulation was probably due to relaxation of the COVID-19 pandemic restriction measures, which greatly reduced the circulation of respiratory-transmitted viruses, including human respiratory syncytial virus (HRSV). The symptoms of SARS-CoV-2 and influenza are quite similar, sharing the human-to-human transmission route via respiratory droplets. The aim of this study was to estimate the rate of coinfection with influenza viruses and/or HRSV in SARS-CoV-2-positive subjects (N=940) in a population of central Italy during the 2021/2022 season. A total of 54 cases of coinfection were detected during the study period, 51 cases (5.4%) of SARS-CoV-2 and influenza virus and three cases (0.3%) of SARS-CoV-2 and HRSV coinfection. These results highlight the importance of continuous monitoring of the circulation of influenza virus and other respiratory viruses in the context of the COVID-19 pandemic.
References
Zhu. N.; Zhang, D.; Wang, W.; Li, X.; Yang. B.; Song. J.; Zhao. X.; Huang. B.; Shi. W.; Lu. R.; Niu. P.; Zhan. F.; Ma. X.; Wang. D.; Xu. W.; Wu. G.; Gao. G. F.; Tan, W.; & China Novel Coronavirus Investigating and Research Team (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020, 382(8).
Civil Protection Department. https://mappe.protezionecivile.gov.it/it/mappe-emergenze/mappe-coronavirus/situazione-desktop (accessed on 26/05/2022)
Krammer. F.; Smith. G.J.D.; Fouchier. R.A.M.; Peiris. M.; Kedzierska. K.; Doherty. P.C.; Palese. P.; Shaw. M.L.; Treanor. J.; Webster.R.G.; García-Sastre. A.. Nat Rev Dis Primers 2018, Jun 28;4(1):3.
Halabi. K.C.; Wang. H.; Leber. A.L.; Sánchez. P.J.; Ramilo, O,; Mejias, A.. Respiratory syncytial virus and SARS-CoV-2 coinfections in children. Pediatr Pulmonol 2022 Dec;57(12):3158-3160.
Flerlage. T.; Boyd. D.F.; Meliopoulos. V.; Thomas. P.G.; Schultz-Cherry. S.. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021 Jul;19(7):425-441.
Ozaras. R.; Cirpin. R.; Duran. A.; Duman. H.; Arslan O.; Bakcan. Y.; Kaya. M.; Mutlu. H.; Isayeva. L.; Kebanlı. F.; Deger. B.A.; Bekeshev. E.; Kaya. F.; Bilir. S.. Influenza and COVID-19 coinfection: Report of six cases and review of the literature. J Med Virol 2020 Nov;92(11):2657-2665.
Istituto Superiore della Sanità, Epicentro. https://www.epicentro.iss.it/influenza/stagione-in-corso (accessed on 01/07/2022)
Istituto Superiore della Sanità, Epicentro. https://www.epicentro.iss.it/influenza/flunews21-22#epi (accessed on 25/10/2023)
Bai. L.; Zhao. Y.; Dong. J.; Liang. S.; Guo. M.; Liu. X.; Wang. X.; Huang. Z.; Sun. X.; Zhang. Z.; Dong. L.; Liu. Q.; Zheng. Y.; Niu. D.; Xiang. M.; Song. K.; Ye. J.; Zheng. W.; Tang. Z.; Tang. M.; Zhou. Y.; Shen. C.; Dai. M.; Zhou. L.; Chen. Y.; Yan. H.; Lan. K.; Xu. K.. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res 2021 Apr;31(4):395-403.
Burrel. S.; Hausfater. P.; Dres. M.; Pourcher. V.; Luyt. C.E., Teyssou. E.; Soulié. C.; Calvez. V.; Marcelin. A.G.; Boutolleau. D. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the di-agnosis of COVID-19. Int J Infect Dis 2021 Jan;102:10-13.
Xiaojuan. Z.; Yiyue. G.; Tao. W.; Kangchen. Z.; Yin. C.; Bin. W.; Fengcai. Z.; Baoli Z.; Lunbiao. C.. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res 2020;285:198005.
Uyeki. T. M.; Hui. D. S., Zambon. M.; Wentworth. D. E.; Monto. Arnold. S.. Influenza. Lancet 2022 Aug 27;400(10353):693-706.
Rapporto Influnet. https://www.iss.it/site/rmi/influnet/pagine/rapportoinflunet.aspx (accessed on 09/02/ 2023).
Steponavičienė. A.; Burokienė. S.; Ivaškevičienė. I.; Stacevičienė. I.; Vaičiūnienė. D.; Jankauskienė. A.. Influenza and respir-atory syncytial virus infections in pediatric patients during the COVID-19 pandemic: a single-center experience. Children (Basel) 2023 Jan 7;10(1):126.
Trifonova. I.; Christova I.; Madzharova. I.; Angelova. S.; Voleva. S.; Ralitsa. Yordanova.; Tcherveniakova. T.; Krumova. S.; Korsun. N.. Clinical significance and role of coinfections with respiratory pathogens among individual with confirmed severe acute respiratory syndrome-2 infection. Front Public Health 2022 Sep 2:10:959319.
Saeedeh. E.; Mojtaba. K.; Barat. B.; Nayeb. F.D.; Zahra. N.; Tahereh. N.; Faezeh. S.. The circulation of common respiratory viruses and their co-infection with severe respiratory syndrome coronavirus 2 before and after coronavirus disease of 2019 vaccination. Jundishapur J Microbiol 2022 December; 15(12):e133326.
Milano. G.; Capitani. E.; Camarri. A.; Bova. G.; Capecchi. P.L.; Lazzeri. G.; Lipari. D., Montomoli. E.; Manini. I,. Surveillance of influenza and other airborne transmission viruses during the 2021/2022 season in hospitalized subjects in Tuscany, Italy. Vaccines (Basel) 2023 Mar 31;11(4):776.
Istituto Superiore della Sanità, Epicentro. https://www.epicentro.iss.it/influenza/flunews#vir (accessed on 26/05/2022).
Istituto Superiore della Sanità, Epicentro. https://www.epicentro.iss.it/ben/2022/4/virus-influenzali-vaccinazioni-influnet-2021-2022 (accessed on 19/12/ 2023).
Adams K, Tastad KJ, Huang S, Ujamaa D, Kniss K, Cummings C, Reingold A, Roland J, Austin E, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Reeg L, Leegwater L, McMahon M, Bye E, Poblete M, Landis Z, Spina NL, Engesser K, Bennett NM, Gaitan MA, Shiltz E, Moran N, Sutton M, Abdullah N, Schaffner W, Talbot HK, Olsen K, Staten H, Taylor CA, Havers FP, Reed C, Budd A, Garg S, O'Halloran A, Brammer L. Prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged <18 years who were hospitalized or died with influenza – United States, 2021-22 influenza season. MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1589-1596. doi: 10.15585/mmwr.mm7150a4.PMID:36520656.
Tang C, Boftsi M , Staudt L., Jane A. McElroy e, Tao Li f , Duong S, Adrienne Ohler g , Detlef Ritter h , Richard Hammer d,h , Jun Hang f , XiuFeng Wan. SARS-CoV-2 and influenza co-infection: a cross-sectional study in central Missouri during the 2021-2022 influenza season. Virology 2022 Nov:576:105-110.doi: 10.1016/j.virol.2022.09.009. Epub 2002 Sep.
Ministero della Salute, https://www.salute.gov.it/portale/p5_1_2.jsp?id=103&lingua=italiano#:~:text=%C3%88%20indicato%20dai%2018%20anni%20di%20et%C3%A0.&text=Il%20vaccino%20vivo%20attenuato%20%C3%A8,tra%202%20e%2018%20anni (accessed on 19/12/2023).
Garg I, Gangu K, Shuja H, Agahi A, Sharma H, Bobba A, Nasrullah A, Chourasia P, Pal S, Sheikh AB, Shekhar R. COVID-19 and Influenza Coinfection Outcomes among Hospitalized Patients in the United States: A Propensity Matched Analysis of National Inpatient Sample. Vaccines (Basel). 2022 Dec 15;10(12):2159. doi: 10.3390/vaccines10122159. PMID: 36560569; PMCID: PMC9783554.
Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M, Hardwick HE; ISARIC4C Investigators; Visser LG, Openshaw PJM, Groeneveld GH, Semple MG, Baillie JK. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022 Apr 16;399(10334):1463-1464. doi: 10.1016/S0140-6736(22)00383-X. Epub 2022 Mar 25. PMID: 35344735; PMCID: PMC8956294.
Cong B, Deng S, Wang X, Li Y. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis. J Glob Health. 2022 Sep 17;12:05040. doi: 10.7189/jogh.12.05040. PMID: 36112521; PMCID: PMC9480863.